FOXP3 and intrahepatic cholangiocarcinoma: Similarly, no correlation was found between prognosis and FoxP3+ Tregs in patients with intrahepatic cholangiocarcinoma (HR = 1.05, 95% CI 0.65 to 1.45; P > .05) or extrahepatic cholangiocarcinoma (HR = 1.07, 95% CI -0.04 to 2.17; P > .05; see Fig. 3).